ag凯发旗舰厅
shanghai clinical research center (scrc) operates as a 3rd-party full-service assessment and resource center to facilitate drug development. scrc is developing a core resource platform with coverage of clinical research sites throughout china. a fully equipped central laboratory with glp capabilities, a state-of-the-art data management and a bio-statistics system position scrc as a leader in drug development services in china.
founded under the collaborative framework of the ministry of science and technology and the shanghai municipality in 2008, scrc endeavors to be a pioneer in the globalization of drug development in china by provision of the link necessary between pharmaceutical companies and hospitals. with superior technical skills, abundant public resources, necessary infrastructure and a network providing access to large patient populations, scrc is dedicated to meeting the challenging needs for clinical expertise, quality services and technological innovation in global drug development.
bearing the commitment to be the practitioner of the national innovation strategy, scrc also hosts a bio-bank and a translational medical research center, which will leverage the research power by bridging the clinical practice and the fundamental research.
capital medical university (cmu) was founded in 1960. it ranks among the top academic medical institutions in china and is one of the key municipal universities in beijing. cmu is a well known academic institution for its strong capacity in scientific research. it hosts many key national and municipal disciplines, laboratories and some exchange stations for post-doctoral research.
the china national genebank (shenzhen) is a national nonprofit institute supported by the government of china.
cngb, as an unincorporated international collaborative institute, is devoted to the comprehensive collection of biological resources (including specimens from humans, and other animals, plants and microorganisms) preservation, bioinformatics data generation and a global network establishment to promote information sharing and exchange. cngb operates through collaborative activities between universities, hospitals and scientific institutes that share an interest in biobanking, resource utilization and bioinformatics.
cngb is committed to developing a biobank consortium across china and the construction of an expanding network worldwide to provide a platform for information sharing and exchange of biobank materials, omics data acquisition, and multi-omics scientific research. working closely with ethical review boards and regulations to secure the data , cngb has set itself the principal task of integrating the contribution of bioresources data into an omics database that will support both scientific research and commercial applications, such as translational medicine, breeding and new energy exploitation.
上海申康医院发展中心
上海申康医院发展中心是市政府设立的国有非营利性的事业法人，是市级公立医疗机构国有资产投资、管理、运营的责任主体和政府办医的责任主体。 一方面，申康医院发展中心受市国资委委托，承担投资举办市级公立医疗机构的职能，对市级公立医疗机构的国有资产实施监督管理，履行出资人职责，承担国有资产保值增效责任；另一方面，作为市政府的办医主体，申康医院发展中心将根据市政府的要求，坚持正确的办医方向，办好市级公立医疗机构，进一步提高市级医疗机构的整体水平，为患者提供质优、价廉的医疗服务。
“上海枫林生命科学联盟”是由徐汇区人民政府和上海市科学技术委员会发起、联合生物医药领域大院大所大校大企共同成立。“枫林联盟”以协同创新、开放合作的理念，对生命科学领域优势资源进行整合联动，旨在推动上海市和徐汇区生物医药原始研发创新和高端产业集聚，激发创新内涵，打造产业高地。“枫林联盟”是一个“双引擎”驱动的开放式协同创新网络联盟。一方面，推动区域内科研院所进行协同创新合作，建设创新高地；另一方面，推动国内外知名医药公司总部集聚，建设产业高地。通过推动有影响力的协同创新合作，实施技术转移与成果转化；营造良好的创新和产业生态环境，推进高端产业组织集聚；搭建功能服务平台，不断完善相关运行机制。
in 2010, scrc starts to organize shanghai engineering research center of biobank under the authorization of shanghai science & technology committee. shanghai engineering research center of biobank aims to offer technical solutions to the construct of standardized biobank in shanghai and provide resource and technical support to the development of biomedical industry.
